Business Description
ZYUS Life Sciences Corp
NAICS : 325412
SIC : 3741
ISIN : CA9899601095
Description
ZYUS Life Sciences Corp is primarily engaged in the global development and commercialization of innovative cannabinoid-based therapeutics and product candidates. It is a licensed producer and distributor of medical cannabis for both medical and adult recreational access in Canada.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.04 | |||||
| Equity-to-Asset | 0.44 | |||||
| Debt-to-Equity | 0.53 | |||||
| Debt-to-EBITDA | -0.2 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | -8.72 | |||||
| Beneish M-Score | -3.84 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 0.42 | |||||
| 9-Day RSI | 0.57 | |||||
| 14-Day RSI | 0.66 | |||||
| 6-1 Month Momentum % | -12.51 | |||||
| 12-1 Month Momentum % | 10.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.24 | |||||
| Quick Ratio | 0.11 | |||||
| Cash Ratio | 0.02 | |||||
| Days Inventory | 4524.89 | |||||
| Days Sales Outstanding | 480.15 | |||||
| Days Payable | 6364.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 22.72 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 56.42 | |||||
| Operating Margin % | -3700 | |||||
| Net Margin % | -8086.95 | |||||
| FCF Margin % | -1697 | |||||
| ROE % | -151.88 | |||||
| ROA % | -82.53 | |||||
| ROIC % | -33.52 | |||||
| ROC (Joel Greenblatt) % | -312.52 | |||||
| ROCE % | -137.35 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 121.43 | |||||
| PB Ratio | 4.25 | |||||
| EV-to-EBIT | -1.69 | |||||
| EV-to-EBITDA | -1.82 | |||||
| EV-to-Revenue | 156.63 | |||||
| EV-to-Forward-Revenue | 125.53 | |||||
| EV-to-FCF | -9.28 | |||||
| Earnings Yield (Greenblatt) % | -59.17 | |||||
| FCF Yield % | -12.07 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ZLSCF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ZYUS Life Sciences Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.333 | ||
| EPS (TTM) ($) | -0.431 | ||
| Beta | 0 | ||
| Volatility % | 105.94 | ||
| 14-Day RSI | 0.66 | ||
| 14-Day ATR ($) | 0.012602 | ||
| 20-Day SMA ($) | 0.032975 | ||
| 12-1 Month Momentum % | 10.17 | ||
| 52-Week Range ($) | 0.0005 - 0.81 | ||
| Shares Outstanding (Mil) | 74.36 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ZYUS Life Sciences Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ZYUS Life Sciences Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
ZYUS Life Sciences Corp Frequently Asked Questions
What is ZYUS Life Sciences Corp(ZLSCF)'s stock price today?
The current price of ZLSCF is $0.00. The 52 week high of ZLSCF is $0.81 and 52 week low is $0.00.
When is next earnings date of ZYUS Life Sciences Corp(ZLSCF)?
The next earnings date of ZYUS Life Sciences Corp(ZLSCF) is .
Does ZYUS Life Sciences Corp(ZLSCF) pay dividends? If so, how much?
ZYUS Life Sciences Corp(ZLSCF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers